Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photobiomodulation for Bell's Palsy
NCT05585346Completed
- Sponsor
- Beijing Tongren Hospital
- Start
- Jan 2021
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in Bell's palsy (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoints: House-Brackmann at 4 weeks and Sunnybrook at 4 weeks. Started Jan 2021; status: completed.
02
Conditions
Bell's palsy
Beyond the preview
Go deeper on NCT05585346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05585346.